Koch Disruptive Technologies — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Cellarescellares.cominApr 2021
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Co-Founder and Chief Executive Officer)inOmar Kurdi(Co-Founder and President)in
BoardJustin Butler(Director)inVictor Tong(Director)in
Co-investorsDecheng Capital8VCEcoR1 CapitalIntuitive VenturesBaillie GiffordBlackRock+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.